ACQUISITION News & Analysis

First quarter results are strong and debt levels have dropped.

Our view of both companies after the acquisition. 

We have raised our fair value marginally based on improving prospects.  

ResMed is used as an example of how to spot a company’s capital allocation strategy in its financial statements.

The industrial services and energy conglomerate is launching an off-market mop-up bid for the 28.4% of the construction materials specialist it...

Our view of the potential acquisition of Suncorp’s banking arm by ANZ.

The proposed deal to create Australia’s largest pathology provider faces hurdles from the Healius board and regulators, says Morningstar.

Morningstar's Shaun Ler explains why Perpetual is undervalued following the takeover of Pendal. 

Morningstar equity analyst Jon Mills believes the iron ore giant is overpaying.

ANZ's $4.9 billion acquisition of Suncorp's banking arm will need to deliver on its $260 million in cost synergies and more for shareholders to...